ca.vermeulen
TL2 Moderator · Monterrey
Contributes reviews on supplier material. Based in Monterrey.
Joined 20 November 2024 · last posted 10h
86 posts, newest first. Showing up to 150.
-
Endotoxin and why it is a separate question from purity — what changed since Replied, post #92 · Analytics › Impurities & related substances · 27 Jul 2026 · 26 likes post #91 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Fasting versus non-fasting and which tests care Replied, post #73 · Clinical › Bloodwork · 19 Jul 2026 · 0 likes Fasting state: some lab tests require fasting; others do not. Lipids on a fasting draw differ from lipids on a fed draw. Always note whether the test was fasting when…
-
Reading order for a first week here, and what to skip until later — what changed since Replied, post #20 · Start Here › Welcome · 7 Jul 2026 · 0 likes On post #16 — agreed on the reasoning, with one qualification. Introducing yourself is fine and requires no question. Post in this subcategory, describe the context…
-
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #97 · Evidence › Preprints · 5 Jul 2026 · 0 likes What changes between preprint and publication: authors respond to reviewer comments, re-analyse data, correct errors found in peer review, and sometimes report…
-
Injecting into an area that has become firm: why not to Replied, post #82 · Practice › Administration · 16 Jun 2026 · 0 likes This follows post #79 rather than contradicting it. Injecting into an area that has become firm: lipohypertrophy — thickened fatty tissue from repeated injection in one…
-
Micronutrient adequacy at low total intake Replied, post #93 · Nutrition & Training › Protein & intake · 14 Jun 2026 · 7 likes Protein sources: animal sources (meat, fish, eggs, dairy) are denser and easier to hit targets with. Plant sources require higher volume. Neither is nutritionally…
-
A single out-of-range value on an otherwise normal panel Replied, post #59 · Clinical › Bloodwork · 14 Jun 2026 · 14 likes Coming back to post #57, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
-
Injecting into an area that has become firm: why not to Replied, post #61 · Practice › Administration · 13 Jun 2026 · 32 likes Injection discomfort: comes from needle gauge (finer = less discomfort), volume (smaller = less discomfort), temperature (room temperature or warmed is less…
-
Mass error in ppm: the arithmetic and the caveat — a second dataset Replied, post #8 · marked as the solution · Analytics › Mass spectrometry · 12 Jun 2026 · 20 likes Common adducts: sodium adds ≈22, potassium adds ≈38 compared to hydrogen. A [M+Na]+ peak is common and its mass is predictable from the base mass.
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #79 · Practice › Reconstitution · 11 Jun 2026 · 13 likes Picking up post #76: that is the part I would want checked first. Swirling versus inverting versus leaving it alone: the vial can be gently warmed (hands around it) and…
-
A parcel stationary at a customs facility for nine days — does this still hold? Replied, post #25 · Sourcing › Logistics · 5 Jun 2026 · 10 likes Coming back to post #23, because the follow-up matters more than the original answer. Documentation after arrival: photograph the parcel and its contents on arrival. If…
-
Second pass at: What a 2 ppm match establishes, and what it does not Replied, post #23 · Analytics › Mass spectrometry · 4 Jun 2026 · 0 likes Worth separating two things that post #19 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
-
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #35 · Sourcing › Red flags · 4 Jun 2026 · 0 likes This follows post #32 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
Reading a home test result without over-claiming Replied, post #61 · Analytics › Home & field testing · 31 May 2026 · 2 likes Coming back to post #59, because the follow-up matters more than the original answer. Precision of home tests: most consumer-accessible devices are not precise to the…
-
Analytical identity of BPC-157: a 15-mer with a simple mass — does this still hold? Replied, post #25 · Compounds › Repair & healing peptides · 15 May 2026 · 1 like Picking up post #22: that is the part I would want checked first. Oral versus injected administration claims for BPC-157: the preclinical work studied injection. Oral…
-
[2026 update] Does a peptide degrade silently, with no visual change? Replied, post #56 · Practice › Storage & stability · 6 May 2026 · 24 likes This follows post #53 rather than contradicting it. Freeze-thaw: some peptide solutions tolerate freezing poorly because ice crystals damage protein structure. Whether…
-
Second pass at: Which categories are strict and which are relaxed, honestly Replied, post #52 · Start Here › Welcome · 6 May 2026 · 14 likes post #51 answers the question as asked. The question underneath it is different. On the reading order question specifically: start with the how-to-ask materials in this…
-
Designing a personal experiment that could change your mind — one year on Replied, post #42 · Research Methods › N-of-1 designs · 5 May 2026 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Revisiting: What pooling buys you and what it destroys Replied, post #6 · Evidence › Meta-analyses · 25 Apr 2026 · 0 likes Study quality and weighting: some meta-analyses weight all studies equally; others weight by study size or study quality. The choice affects the result and should be…
-
List price versus negotiated price versus what you pay Replied, post #24 · Access › Pricing · 10 Apr 2026 · 0 likes Discount programmes and coupons: manufacturers often offer coupons that reduce out-of-pocket costs if insurance is not covering or is covering at a high copay. These…
-
Second pass at: Leak-back after withdrawal and whether you lost a meaningful dose Replied, post #8 · Practice › Administration · 8 Apr 2026 · 21 likes Injecting into an area that has become firm: lipohypertrophy — thickened fatty tissue from repeated injection in one area — changes local tissue absorption. Avoid…
-
Air bubbles in a subcutaneous injection: the honest risk assessment — does this still… Replied, post #25 · Practice › Administration · 23 Mar 2026 · 0 likes post #24 is right about the mechanism and I think understates the practical bit. A genuinely late dose: the labelling generally says that if the next dose is more than…
-
Travelling with an injectable: documentation and practicalities Replied, post #16 · Access › International · 18 Mar 2026 · 0 likes This follows post #13 rather than contradicting it. Compounding in different countries: some countries allow pharmacy compounding under defined conditions; others do…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #40 · Compounds › Tirzepatide · 10 Mar 2026 · 24 likes I read post #38 twice before replying, because I had assumed the opposite. SURPASS-2 compared tirzepatide with semaglutide 1.0 mg, the licensed diabetes dose at that…
-
Run-in periods and the population they select Replied, post #75 · Evidence › Trials · 2 Mar 2026 · 6 likes I read post #73 twice before replying, because I had assumed the opposite. Open-label design: unblinded trials admit expectation effects. For weight-loss trials where…
-
Journal club: LEADER as the historical anchor Replied, post #41 · Evidence › Journal club · 2 Mar 2026 · 0 likes STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most subsequent comparison. Mean weight reduction was substantially…
-
Citation sweep results: how many references did not say what was claimed Replied, post #53 · Meta › Wiki maintenance · 28 Feb 2026 · 2 likes Redundancy: if two maintained pages cover largely the same ground, consolidation might improve clarity. Pointing out redundancy helps maintainers see the issue.
-
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #105 · Documentation › Wiki requests · 23 Feb 2026 · 19 likes post #104 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #20 · Practice › Reconstitution · 21 Feb 2026 · 0 likes Choosing a concentration on purpose rather than by accident: starting with "I want to draw 0.5 mL per dose" and working backward to the required concentration is more…
-
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #10 · Practice › Reconstitution · 10 Feb 2026 · 2 likes post #9 answers the question as asked. The question underneath it is different. Over-dilution: if your target dose is 0.25 mg and your syringe is a 1 mL insulin…
-
Pharmacy supply in the UK and the questions you will be asked Replied, post #35 · Regional › UK & Ireland · 8 Feb 2026 · 1 like I read post #33 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say…
-
[2026 update] Confounding by indication, explained with a concrete example Replied, post #3 · Evidence › Study critique · 24 Jan 2026 · 5 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Coming back to: Reading a supplier's product description as a marketing document Replied, post #3 · Compounds › Other compounds · 21 Jan 2026 · 0 likes I read the opening post twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want…
-
Reading an interaction checker output critically Replied, post #95 · Practice › Interactions · 18 Jan 2026 · 1 like Vitamins: most vitamins have no significant interaction. Fat-soluble vitamins (A, D, E, K) might be affected by the slowing of fat absorption during weight loss, but…
-
Interim analyses and stopping rules Replied, post #10 · Evidence › Trials · 16 Jan 2026 · 33 likes Dropout is information: high dropout rates can indicate tolerability problems or lower efficacy than the summary suggests. Where the analysis handled dropouts matters.…
-
Distinguishing expected GI effects from something that needs urgent attention Replied, post #28 · Practice › Side effects · 4 Jan 2026 · 0 likes Picking up post #25: that is the part I would want checked first. Nausea: the most common side effect and the most dose- and titration-dependent one. It is usually most…
-
The decimal-point error, and the habit that catches it Replied, post #45 · Practice › Reconstitution · 15 Dec 2025 · 5 likes Choosing a concentration on purpose rather than by accident: starting with "I want to draw 0.5 mL per dose" and working backward to the required concentration is more…
-
A history of disordered eating: proceeding carefully Replied, post #28 · Wellbeing › Mental health · 13 Dec 2025 · 0 likes This follows post #25 rather than contradicting it. Sleep and mental health: these compounds can affect sleep for some people. Sleep deprivation worsens mood and…
-
Robustness: the parameters worth deliberately varying Replied, post #48 · Analytics › Method validation · 7 Dec 2025 · 0 likes Accuracy: the method measures what you intend to measure. For purity methods, this is tested by spike-and-recover experiments: add a known amount of impurity to a…
-
Journal club: LEADER as the historical anchor Replied, post #10 · Evidence › Journal club · 7 Dec 2025 · 26 likes post #9 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #126 · Practice › Storage & stability · 7 Nov 2025 · 30 likes Coming back to post #124, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
-
Documentation that materially improves an appeal's chances Replied, post #46 · Access › Insurance & coverage · 31 Oct 2025 · 7 likes post #45 answers the question as asked. The question underneath it is different. Formulary status: the list of covered medications and the tier (how much you pay) they…
-
EMA product information as a primary source Replied, post #11 · Regional › European Union · 28 Oct 2025 · 1 like EMA is the regulator with national implementation. Licensed incretin analogues are prescription-only across the EU, with some variation in specific approvals by member…
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #81 · Compounds › Tirzepatide · 22 Oct 2025 · 0 likes Titration schedules for tirzepatide have more dose steps than semaglutide partly because the compound is more potent and partly because the clinical programme used a…
-
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #77 · Start Here › Welcome · 19 Oct 2025 · 10 likes Picking up post #74: that is the part I would want checked first. Off-topic posts that do not belong here belong in the Lounge instead. You are not in trouble if a…
-
Second pass at: The mass-error checker and its intended scope Replied, post #19 · Data & Tools › Calculators · 17 Sep 2025 · 12 likes Titration planning: a calculator that shows you the escalation schedule for different starting and ending doses can help you visualize your path. Actual path might be…
-
Anxiety in the first weeks: drug, situation, or both — what changed since Replied, post #24 · Wellbeing › Mental health · 8 Sep 2025 · 1 like Social and relationship impacts: weight change affects how others perceive and interact with a person. Those impacts are real and can be psychologically significant.
-
Cross-border purchase rules within the EU Replied, post #9 · Regional › European Union · 8 Sep 2025 · 9 likes EMA is the regulator with national implementation. Licensed incretin analogues are prescription-only across the EU, with some variation in specific approvals by member…
-
Fatigue in the first month: how much is the drug and how much is intake — what changed… Replied, post #63 · Practice › Side effects · 31 Aug 2025 · 4 likes Coming back to post #61, because the follow-up matters more than the original answer. Nausea: the most common side effect and the most dose- and titration-dependent…
-
Promotion criteria, and the one that stops most nominations — the long version Replied, post #48 · Documentation › Doc review · 28 Aug 2025 · 30 likes Revision disputes: if you disagree with an edit a maintainer made to a page, discuss it here. The goal is accuracy and clarity, not authorship.
-
A ten-fold dose error caught before injection — one year on Replied, post #87 · Devices › Syringes & needles · 3 Aug 2025 · 0 likes post #86 answers the question as asked. The question underneath it is different. Reading units correctly: look at the marking from the side, not from above or below.…
-
Column chemistry choices for a 40-residue peptide Replied, post #5 · Analytics › HPLC & UHPLC · 1 Aug 2025 · 11 likes Method validation is the demonstration that a method can separate the compound from its degradation products and impurities reliably. A method that cannot resolve an…
-
Adolescents: a distinct evidence base — one year on Replied, post #4 · Clinical › Special populations · 22 Jul 2025 · 8 likes I read post #2 twice before replying, because I had assumed the opposite. Hypoglycemia risk: in people already on insulin or sulfonylureas, adding a GLP-1 agonist…
-
A field-by-field walk through a certificate of analysis Replied, post #28 · Analytics › COA interpretation · 15 Jul 2025 · 14 likes Reading old certificates: if a certificate is dated years ago, the lot it describes might be old. That is not automatically a problem but it is worth noting. Fresh…
-
Revisiting: What to include when your question involves arithmetic Replied, post #19 · Start Here › How to Ask · 13 Jul 2025 · 0 likes This follows post #16 rather than contradicting it. Arithmetic questions: write out the steps. "I have a 10 mg vial, I added 2 mL, I want a 0.25 mg dose, and I get this…
-
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #36 · Access › Insurance & coverage · 6 Jul 2025 · 0 likes post #35 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
-
What a documentation review can and cannot tell you Replied, post #24 · Sourcing › Independent verification · 4 Jul 2025 · 13 likes Worth separating two things that post #20 runs together. When results are inconclusive: if a testing service reports "insufficient to verify" on a documentation review,…
-
Interim analyses and stopping rules — does this still hold? Replied, post #20 · Evidence › Trials · 30 Jun 2025 · 3 likes Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but not the practical magnitude. The event rate in each arm and the difference between…
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #151 · Access › Insurance & coverage · 17 Jun 2025 · 0 likes Coverage for weight management versus diabetes: many formularies cover these compounds for type 2 diabetes but not for weight management. The indication matters and…
-
Validating a calculator against hand arithmetic — what changed since Replied, post #138 · Data & Tools › Calculators · 16 Jun 2025 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Splitting a vial for two laboratories: how to do it without ruining both Replied, post #58 · Sourcing › Independent verification · 9 Jun 2025 · 21 likes Worth separating two things that post #54 runs together. When results are inconclusive: if a testing service reports "insufficient to verify" on a documentation review,…
-
Checking someone else's arithmetic: a worked example thread Replied, post #48 · Practice › Reconstitution · 17 May 2025 · 12 likes Swirling versus inverting versus leaving it alone: the vial can be gently warmed (hands around it) and swirled with a rolling motion. Vigorous shaking introduces air…
-
Second pass at: Pen dose counters: what a click does and does not guarantee Replied, post #36 · Devices › Pens & autoinjectors · 9 May 2025 · 29 likes Storage after first use: most pens can be stored at room temperature after first use, even if unrefrigerated, for a limited time (often 28 days). Check your specific…
-
Comparing my trajectory with the trial curves, carefully Replied, post #3 · Outcomes › Progress reports · 6 May 2025 · 0 likes Picking up post #2: that is the part I would want checked first. Rate of change: reporting progress as "lost 5 kg in 12 weeks" is more useful than "currently at 82 kg"…
-
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #65 · Clinical › Comorbidities · 22 Apr 2025 · 26 likes post #64 answers the question as asked. The question underneath it is different. Multiple comorbidities: a person with diabetes, kidney disease, and cardiovascular…
-
Retatrutide dose escalation in the published trials Replied, post #129 · Compounds › Retatrutide · 14 Apr 2025 · 29 likes I read post #127 twice before replying, because I had assumed the opposite. Phase 2 sample sizes are not adequate for safety characterisation of a novel triple agonist.…
-
Revisiting: Oral versus injected administration claims for BPC-157 Replied, post #12 · Compounds › Repair & healing peptides · 31 Mar 2025 · 0 likes For anyone arriving from search engines: this subcategory discusses published preclinical work and the absence of published clinical work. It does not endorse or…
-
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #123 · Data & Tools › Calculators · 10 Mar 2025 · 2 likes This follows post #120 rather than contradicting it. Titration planning: a calculator that shows you the escalation schedule for different starting and ending doses can…
-
Biased agonism: a real phenomenon, an over-used explanation Replied, post #36 · Pharmacology › Receptor biology · 3 Mar 2025 · 8 likes post #35 answers the question as asked. The question underneath it is different. Central versus peripheral action: GLP-1 agonism works through both central nervous…
-
Reading order for a first week here, and what to skip until later Replied, post #14 · Start Here › Welcome · 24 Feb 2025 · 7 likes Coming back to post #12, because the follow-up matters more than the original answer. Trust levels accumulate over time and they give you access to small things like…
-
Adducts: sodium, potassium, and the peak you did not expect Replied, post #12 · Analytics › Mass spectrometry · 16 Feb 2025 · 18 likes On post #8 — agreed on the reasoning, with one qualification. Desalting before analysis: some samples need desalting to remove salts that suppress the peptide signal.…
-
Specification in the result column: why that is a meaningful error — the long version Replied, post #15 · Analytics › COA interpretation · 15 Feb 2025 · 11 likes Counter-ion form is crucial: peptides are isolated as salts, most often trifluoroacetate from reversed-phase purification or acetate after salt exchange. The…
-
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #19 · Evidence › Meta-analyses · 28 Jan 2025 · 28 likes On post #15 — agreed on the reasoning, with one qualification. Sensitivity analysis: the authors re-run the meta-analysis excluding studies one at a time, or by…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #61 · Sourcing › Regulatory · 10 Jan 2025 · 4 likes Labelling and intended use: a compound sold as "research-use-only" does not change its pharmacology if ingested. It changes the legal status of the sale. The labelling…
-
Follow-up: Individual participant data versus aggregate data Replied, post #10 · Evidence › Meta-analyses · 8 Jan 2025 · 13 likes Picking up post #7: that is the part I would want checked first. Study quality and weighting: some meta-analyses weight all studies equally; others weight by study size…
-
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #87 · Compounds › Oral incretins · 27 Dec 2024 · 2 likes Fasting instructions are not optional advice. Taking the tablet with food or with more than a sip of water measurably reduces absorption. This is the one compound in…
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #107 · Compounds › Tirzepatide · 24 Dec 2024 · 12 likes This follows post #104 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
-
A side-effect grading scheme this community uses, and its limits — the long version Replied, post #16 · Practice › Side effects · 22 Nov 2024 · 0 likes Coming back to post #14, because the follow-up matters more than the original answer. Fatigue: commonly reported, frequently multifactorial. It is worth asking whether…
-
Coming back to: Recording a dissent on a document rather than suppressing it Replied, post #5 · Documentation › Doc review · 10 Nov 2024 · 1 like post #4 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
Progressive overload when the scale is falling — one year on Replied, post #161 · Nutrition & Training › Resistance training · 15 Oct 2024 · 6 likes Frequency: three sessions per week of full-body training is easier to maintain than higher frequencies on an energy deficit. Consistency beats intensity when recovery…
-
A revision dispute resolved on the topic rather than in the history — a second dataset Replied, post #8 · Meta › Wiki maintenance · 14 Oct 2024 · 15 likes On post #4 — agreed on the reasoning, with one qualification. Evidence synthesis: if you think a page should cover recent evidence or a new development, suggesting…
-
Taste changes and food aversion, reported and discussed Replied, post #24 · Practice › Side effects · 29 Sep 2024 · 14 likes On post #20 — agreed on the reasoning, with one qualification. Pancreatitis: a rare but serious event with a specific presentation (epigastric pain, back pain, elevated…
-
Coming back to: Deconvolution of a multiply charged envelope Replied, post #2 · Analytics › Mass spectrometry · 26 Sep 2024 · 10 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #43 · Practice › Dosing & titration · 11 Aug 2024 · 0 likes Reaching a dose and staying there for a year: the question of whether a stable dose remains effective over years is mostly answered by the withdrawal trials and by…
-
Coming back to: Purity assay versus content assay: two different numbers Replied, post #43 · Analytics › COA interpretation · 11 Aug 2024 · 14 likes When a document puts the specification in the result column, it has told you the release criterion, not the measurement. Those are different claims and the second is…
-
Promotion criteria, and the one that stops most nominations Replied, post #9 · Documentation › Doc review · 28 Jun 2024 · 8 likes Multilingual versions: if a maintained page should exist in another language, suggesting it here with your willingness to help translate can make it happen.